Thomas Hanke studied Pharmacy at the Goethe University in Frankfurt. He did his PhD in the group of Prof. Dr. Schubert-Zsilavecz at Frankfurt University which included a sabbatical in the group of Prof. Dr. Werz at the University of Tübingen to study the anti-inflammatory responses of small molecules in vitro and in cellular systems. In 2014, he completed his PhD in pharmaceutical chemistry, investigating the synthesis and pharmacological characterisation of dual 5-LO and mPGES-1 inhibitors. In 2016, he joined the group of Prof. Dr. Knapp as a Post-Doc. Since 2020, he has been a Principal Investigator at SGC's Frankfurt site focusing on the development of selective chemical probes for kinases, with a primary focus on macrocyclic inhibitors.